ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Growing Pains: The Real Story Behind Gen AI Development In Clinical Trial Ops

  As Gen AI develops and reaches advanced stages it introduces risks such as model hallucinations, which can affect trial accuracy and reliability. Explore how to address these challenges.

• EDC Selected To Support Biotech Advances In Diabetes

  Find out why one leading biotechnology company keeps choosing this eClinical technologies and services provider for EDC assistance.

• Breaking Free From Process Paralysis In Clinical Trials

  Explore the implementation of CRIO’s eSource solution by a leading pharmaceutical company to overcome process paralysis in clinical research.

• Achieving Self Sufficiency In Data Collection For Optinose

  Uncover how this specialty pharmaceutical company was able to gain control over its EDC environment by adopting a solution their team could use in-house.

• 5 Best Practices For Getting Started With ePRO

  Unlock the potential of electronic Patient Reported Outcomes (ePRO) in your clinical research by implementing these essential best practices for success.

• Increase Participant Diversity With eClinical Tools

  The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.

• Your CRAs Aren't Monitoring. They're Managing Workarounds.

  CRA productivity rises when monitoring shifts from manual tasks to streamlined access, standardized workflows, and proactive oversight — freeing time for engagement, data quality, and patient safety.

• What The Joint FDA And EMA's AI Principles Can Mean For Clinical Trial Technology

  New FDA/EMA principles align global expectations for AI in drug trials, emphasizing transparency, human-centric design, and risk-based governance to ensure data integrity and patient safety.

• A Blueprint For Modern Obesity Research

  The landscape of obesity and GLP-1 research has reached a saturation point. To successfully scale to the 5,000-patient registries now required for long-term evidence, a shift in operational architecture is essential.

• The Top 5 Myths About eCOA In 2025

  Projected to grow 16.1% annually through 2030, eCOA solutions are booming. Uncover the top five myths and misconceptions about eCOAs in 2025 so your clinical teams can make evidence-based decisions.